Humanwell Healthcare Group has patented a bioavailable liquid composition containing various active ingredients like guaifenesin and phenylephrine HCl. The clear liquid remains stable for up to 2 years at room temperature. GlobalData’s report on Humanwell Healthcare Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Humanwell Healthcare Group, Cancer treatment biomarkers was a key innovation area identified from patents. Humanwell Healthcare Group's grant share as of May 2024 was 50%. Grant share is based on the ratio of number of grants to total number of patents.
Bioavailable liquid composition with active ingredients for pharmaceutical use
A recently granted patent (Publication Number: US12005037B2) discloses a clear bioavailable liquid composition designed for pharmaceutical use. The composition includes specific active ingredients such as guaifenesin, phenylephrine HCl, dextromethorphan HBr, and pseudoephedrine HCl in varying concentrations. The formulation also contains a matrix comprising poly(alkylene glycol) and a polymeric solubilizing agent like polyvinylpyrrolidone. Notably, the liquid composition remains clear without recrystallization for up to 2 years at room temperature, ensuring stability and efficacy over time.
Furthermore, the patent details specific compositions within the clear bioavailable liquid formulation, ranging from combinations of guaifenesin with phenylephrine HCl, dextromethorphan HBr, or pseudoephedrine HCl in precise quantities. The formulations also include pharmaceutically acceptable polyethylene glycol, propylene glycol, and polyvinylpyrrolidone to enhance solubility and bioavailability. Additionally, the patent extends to a pharmaceutical composition in the form of a soft gelatin capsule containing the clear bioavailable liquid composition, providing a convenient dosage form for administration. These innovative formulations aim to improve the delivery and effectiveness of the active ingredients for therapeutic purposes.
To know more about GlobalData’s detailed insights on Humanwell Healthcare Group, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
